Bionik Laboratories to Present at Two Upcoming Investor

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Bionik Laboratories to Present at Two Upcoming Investor Conferences in September 2016

– 2016 Aegis Growth Conference Presentation with Live Webcast on Wednesday, September 21 at 10:30 a.m. PT –

– OktoberINVESTfest Presented by Joseph Gunnar 5 th Annual Investors Conference Presentation with Live Webcast on Wednesday, September 28 at 5:20 p.m. ET –

TORONTO and BOSTON, Sept. 14, 2016 (GLOBE NEWSWIRE) -- Bionik Laboratories Corp. (OTCQX:BNKL) (“Bionik” or the "Company"), a global pioneering robotics company focused on providing rehabilitation solutions to individuals with neurological disorders announced today that Peter Bloch, Chief Executive Officer and Chairman of the Board will present at two upcoming investor conferences in September.

During his presentations, Mr. Bloch will provide a corporate update and discuss Bionik's product portfolio focused on upper and lower extremity rehabilitation for stroke and paraplegic patients, including the Company’s three commercial products on the market and three products in development.

Event:   2016 Aegis Growth Conference Date:  Wednesday, September 21, 2016 Time:  10:30 a.m. Pacific Time Location:  The Encore at Wynn Las Vegas, Las Vegas, NV

Event:   OktoberINVESTfest presented by Joseph Gunnar 5 th Annual Investors Conference Date:  Wednesday, September 28, 2016 Time:  5:20 p.m. Eastern Time Location:  The New York Academy of Sciences, New York, NY

Live webcasts of both presentations will be available on Bionik's IR Calendar in the Investor Relations section of the Company's website ( www.bioniklabs.com ). The webcast replays will be available for approximately two hours after the presentations end and will be archived for 30 days.

About Bionik Laboratories Bionik Laboratories (OTCQX:BNKL), is a global, pioneering robotics company focused on providing rehabilitation solutions to individuals with neurological disorders. The Company has a portfolio of products focused on upper and lower extremity rehabilitation for stroke and paraplegic patients, including three products on the market and three products in varying stages of development. The InMotion Systems - the InMotion ARM™, InMotionWrist™, InMotion Hand™ and InMotion Ankle™, are designed to provide intelligent, patient-adaptive therapy in a manner that has been clinically verified to maximize neuro-recovery. Bionik is also developing a lower-body exoskeleton, ARKE™, designed to allow paraplegics as well as other wheelchair users the ability to rehabilitate through walking. ARKE is expected to be designed to continually adapt to a patient’s ability and provide real time feedback to the physiotherapist through the use of Bionik’s proprietary data collection and analytics cloud network through its partnership with IBM.

For more information, please visit www.bioniklabs.com and connect with us on  Twitter , LinkedIn  and  Facebook .

Forward-Looking Statements Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, statements regarding (i) the plans and objectives of management for future operations, including plans or objectives relating to the design, development and commercialization of human exoskeletons and other rehabilitation products, (ii) a projection of income (including income/loss), earnings (including earnings/loss) per share, capital expenditures, dividends, capital structure or other financial items, (iii) the Company's future financial performance, (iv) the successful integration of IMT with Bionik and (v) the assumptions underlying or relating to any statement described in points (i), (ii), (iii) or (iv) above. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the Company's current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, many of which the Company has no control over. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the Company's inability to obtain additional financing, the significant length of time and resources associated with the development of our products and related insufficient cash flows and resulting illiquidity, the Company's inability to expand the Company's business, significant government regulation of medical devices and the healthcare industry, lack of product diversification, volatility in the price of the Company's raw materials, and the Company's failure to implement the Company's business plans or strategies. These and other factors are identified and described in more detail in the Company's filings with the SEC. The Company does not undertake to update these forward-looking statements.

Bionik Laboratories, Inc. Investor and Media Contact: Jenene Thomas Jenene Thomas Communications, LLC (908) 996-0239 jenene@jenenethomascommunications.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Instanodes Tackling Quantum Threats in Blockchain

Updated Category News Views 0

Diving Into Quantum Cryptography for Blockchain Instanodes is throwing down the gauntlet for the blockchain crowd as the field of quantum computing edges ever closer to unsettling the cryptographic order. This company's latest play? Post-quantum account engineering for major players like Ethereum and Solana. And it's not just tinkering—they're giving the status quo a...

Continue Reading
Envision's Green Ammonia Powers Game-Changing Shipping Milestone

Updated Category News Views 71

Envision's Big Bet on Green Ammonia It's a day to talk about paradigms shifting on the high seas. Envision, a heavy hitter in the green tech arena, just fueled the very first Very Large Ammonia Carrier (VLAC) with their certified green ammonia. Now, that's not just a milestone, it’s like finding a four-leaf clover in the world of maritime decarbonization—a tough nut...

Continue Reading
i-80 Gold's Q3 2026: Production Plans Unveiled

Updated Category News Views 62

Gold Miners on the Move: Eye on i-80 Wake up and smell the gold, folks. i-80 Gold is ramping up to increase its yearly gold production targets, aiming for a hefty 150,000 to 200,000 ounces by 2028. Now, if you’ve been around the block like me, you know these are the kind of numbers that get investors either shifting in their chairs or springing to their feet. A Brief...

Continue Reading
ACA 2027 Enrollment: New Rules Aim to Simplify Coverage

Updated Category News Views 91

Navigating New Waters in 2027 ACA Open Enrollment If you're one of those folks who likes to wait until the last minute, the ACA's got a wake-up call for you this year. The 2027 open enrollment period started on November 1, 2026, with some pretty notable changes. The deadline for coverage beginning January 1, 2027, is December 15, so don't take a nap on this one, alright?...

Continue Reading
HARIBO Unveils Five Boldly Colored Gummies

Updated Category News Views 239

HARIBO's New Fruity Lineup: A Sweet Adventure Hey folks, grab a bag of these new HARIBO gummies, and you're in for a fruity ride. The candy maker's got a new trick up its sleeve with five whimsical, boldly colored gummies. They've dubbed these little treats single-flavor goodies—each with one distinct shape and taste. It's a marketing move that screams 'collect them...

Continue Reading
D-Wave Faces Securities Fraud Class Action: Details Inside

Updated Category News Views 41

D-Wave Quantum Inc. in Hot Water Well folks, looks like D-Wave Quantum Inc. (NASDAQ: QBTS) is knee-deep in a securities fraud class action lawsuit. This ain't just another day in the quantum computing trenches. We've got Kessler Topaz Meltzer & Check, LLP, a big player in securities litigation, rallying the troops here—a clear sign that this case is packing some hefty...

Continue Reading
Oracle's $20 Billion Offering: What Investors Need to Know

Updated Category News Views 97

Oracle's Big Play: A $20 Billion Offering Nobody said playing in the big leagues was easy, and Oracle seems to be doubling down on that idea. Today, they spilled the beans on their ambition to rake in a cool $20 billion through an offering of common stock and senior notes. For those of us who keep a close eye on NYSE:ORCL, this is more than just a number—it's a signal...

Continue Reading
New Study Exposes Grim Reality for Moderate Aortic Stenosis

Updated Category News Views 95

Uncovering the Stark Truth of Moderate Aortic Stenosis When you hear about heart issues, the last thing you want to think about is moderate anything. But this study out of San Diego sure throws a wrench in how we size up moderate aortic stenosis. Turns out these patients aren't just in a holding pattern—they're facing some serious storm clouds. High Stakes for...

Continue Reading
XPENG Eyes South Korea Entry with Industry Veteran

Updated Category News Views 109

A Veteran's Task in a New Territory Piling onto its international ambitions, XPENG has roped in Lee Man-sik, a seasoned auto industry professional, to break into South Korea. South Korea isn’t just another market—it’s one of the toughest stages for the automotive industry. The customers there are sharp, with a keen eye for tech and quality. So XPENG, trading under...

Continue Reading
Andrea P. Davis: A Leadership Luminary Honored

Updated Category News Views 161

A Decade-Spanning Influence in Leadership After years of helping executives navigate the twists and turns of organizational life, Andrea P. Davis stands out as The Inner Circle's Pinnacle Professional of the Year. With over 25 years under her belt, Davis has tackled strategic planning, brand development, and organizational transformation like a prizefighter in the ring....

Continue Reading

Top 5 Most Recently Viewed Articles

Learnologyworld Launches New Domain and Strategic Partnerships

Updated Category News Views 239

Learnologyworld made waves in the online IT training scene by launching its new domain, learnologyworld.net, back in 2024. This wasn't just a simple rebranding; it was a tactical move signaling their expansion and serious commitment to user experience. Traders tuned into this transition because a domain change can often indicate a firm’s strategic pivot—especially in...

Continue Reading
Trump's Advisory Team Proposes Changes to Mining Regulations

Updated Category News Views 181

Trump Administration's Shift on Mining Regulations Advisors to the incoming administration of Donald Trump have put forth significant recommendations regarding mining regulations in the United States. With a focus on enhancing domestic production of critical minerals essential for technologies like electric vehicles and electronics, they propose waiving environmental...

Continue Reading
Vinci Partners to Discuss Strategic Growth in Upcoming Webcast

Updated Category News Views 166

Vinci Partners to Host Virtual Webcast Vinci Partners Investments Ltd. (NASDAQ: VINP) is excited to announce a virtual webcast aimed at exploring the combination with Compass. This event is scheduled for a future date at 8:00 AM ET, where the team will delve into the ongoing integration, synergies, and strategic vision for future growth across Latin America. What to...

Continue Reading
Sale Shifts Gregg Young Chevrolet to New Owners

Updated Category News Views 121

Dealership Transition: A New Chapter in Marshalltown Get this—Gregg Young Chevrolet in Marshalltown, Iowa, is changing hands. This isn't some overnight affair; we're talking about a dealership that's been around and has history in the state. The keys are being passed from the Gregg Young Automotive Group to Alan Reuber and Matthew Barrows, under the stewardship of North...

Continue Reading
Promising Results for Rinatabart Sesutecan in Cancer Trials

Updated Category News Views 229

Rinatabart Sesutecan: A Major Advancement in Cancer Treatment Rinatabart sesutecan (Rina-S) has emerged as a promising option in the battle against ovarian and endometrial cancers. Recent findings from a Phase 1/2 clinical trial emphasize its effectiveness, especially among patients who have already gone through several treatments. This investigational therapy targets...

Continue Reading